Reuters

U.S. jury finds AbbVie liable for misrepresentation in AndroGel verdict

NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 ...
Benzinga.com

AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case

AbbVie Inc (NYSE:ABBV) has petitioned the U.S. Supreme Court to protect its corporate records, arguing that a lower court ruling threatens the confidentiality of attorney communications. The ...
FiercePharma

AbbVie asks Supreme Court to uphold attorney-client privilege in AndroGel lawsuit

AbbVie is asking the U.S. Supreme Court to overrule a lower court’s ruling that the company must turn over records of communications with its lawyers regarding a patent lawsuit it filed against a ...
Reuters

U.S. regulators challenge AndroGel patent pacts

WASHINGTON, Feb 2 (Reuters) - Federal and state regulators have challenged agreements made by Solvay SA with generic drug companies Watson Pharmaceuticals Inc , Par Pharmaceuticals and Paddock ...